Holen Sie sich die Stockscreener-App
148.99
2.81%
-4.30
Schlusskurs vom Vortag:
$153.29
Offen:
$153.69
24-Stunden-Volumen:
1.68M
Relative Volume:
0.94
Marktkapitalisierung:
$26.72B
Einnahmen:
$15.50B
Nettoeinkommen (Verlust:
$1.33B
KGV:
20.30
EPS:
7.34
Netto-Cashflow:
$2.16B
1W Leistung:
-2.93%
1M Leistung:
-5.11%
6M Leistung:
-32.04%
1J Leistung:
-35.00%
1-Tages-Spanne:
$148.74
$154.99
1-Wochen-Bereich:
$143.65
$156.50
52-Wochen-Spanne:
$135.97
$252.88
Iqvia Holdings Inc Stock (IQV) Company Profile
Firmenname
Iqvia Holdings Inc
Sektor
Branche
Telefon
919-998-2000
Adresse
2400 ELLIS ROAD, DURHAM, NC
Vergleichen Sie IQV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
148.99 | 26.72B | 15.50B | 1.33B | 2.16B | 7.34 |
|
TMO
Thermo Fisher Scientific Inc
|
403.13 | 159.89B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.73 | 142.45B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
491.70 | 37.95B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
106.93 | 30.97B | 6.53B | 1.26B | 1.31B | 4.35 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-25 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-02-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-12-20 | Eingeleitet | Stephens | Overweight |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-09-04 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-15 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-02-13 | Eingeleitet | BTIG Research | Buy |
| 2023-11-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-03-17 | Eingeleitet | Truist | Buy |
| 2022-12-06 | Eingeleitet | Cowen | Outperform |
| 2022-11-17 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
| 2022-05-24 | Eingeleitet | Guggenheim | Buy |
| 2022-04-29 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-16 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2020-07-07 | Eingeleitet | Stephens | Equal-Weight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-12-13 | Hochstufung | CFRA | Sell → Hold |
| 2019-11-14 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | Hochstufung | Mizuho | Neutral → Buy |
| 2019-05-28 | Eingeleitet | SVB Leerink | Outperform |
| 2019-01-18 | Hochstufung | Jefferies | Hold → Buy |
| 2018-10-09 | Eingeleitet | UBS | Buy |
| 2018-10-02 | Bestätigt | Robert W. Baird | Outperform |
| 2018-07-25 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | Bestätigt | Stifel | Buy |
| 2018-07-03 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | Hochstufung | Goldman | Neutral → Buy |
| 2018-03-07 | Hochstufung | SunTrust | Hold → Buy |
| 2018-01-19 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Iqvia Holdings Inc Aktie (IQV) Neueste Nachrichten
IQVIA: Q1 Earnings Support Steady Optimism (NYSE:IQV) - Seeking Alpha
IQVIA raises 2025 revenue guidance amid strong TAS growth and expanded AI deployment - MSN
Morgan Stanley Adjusts Price Target on IQVIA Holdings to $185 From $250, Maintains Overweight Rating - marketscreener.com
IQVIA Holdings Inc. (NYSE:IQV) Q1 2025 Earnings Call Transcript - MSN
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13 - Business Wire
Barclays Lowers IQVIA Holdings (IQV) Price Target to $165 Amid Demand Concerns | IQV stock price - paginasiete.bo
IQVIA (IQV) Target Price Lowered by UBS, Rating Maintained | IQV Stock News - GuruFocus
IQVIA Holdings (IQV): Barclays Lowers Price Target to $165 | IQV Stock News - GuruFocus
Stephens Adjusts Price Target on IQVIA Holdings to $200 From $250, Maintains Overweight Rating - marketscreener.com
Citigroup Adjusts Price Target on IQVIA Holdings to $160 From $210, Maintains Neutral Rating - marketscreener.com
Baird Adjusts Price Target on IQVIA Holdings to $161 From $195, Maintains Neutral Rating - marketscreener.com
Barclays Adjusts Iqvia (IQV) Price Target Amid Demand Concerns | IQV Stock News - GuruFocus
IQVIA Holdings Inc (IQV) Q1 2025 Earnings Call Highlights: Stron - GuruFocus
IQVIA: Q1 Earnings Snapshot - CTPost
Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight - GuruFocus
IQVIA Holdings Reports Strong Q1 2025 Results - TipRanks
IQVIA (IQV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
IQVIA Q1 2025 Earnings Call Transcript - MarketBeat
IQVIA Holdings’ Earnings Call: Mixed Sentiment Amid Growth - TipRanks
IQVIA Q1 2025 slides: Revenue up 2.5%, adjusted EPS beats expectations - Investing.com Nigeria
IQVIA HOLDINGS INC. SEC 10-Q Report - TradingView
IQVIA Holdings (NYSE:IQV) Reports US$3,829 Million Sales Q1 2025; Raises Full-Year Revenue Guidance - Yahoo Finance
Questex’s Fierce Pharma Announces the 2025 Fierce Pharma Marketing Awards Call for Submissions - GlobeNewswire Inc.
IQVIA Earnings & Revenues Beat Estimates in Q1, Increase Y/Y - TradingView
IQVIA Holdings Inc. Reports Impressive Q1 CY2025 Financial ResultsNews and Statistics - IndexBox
Earnings call transcript: IQVIA Holdings beats Q1 2025 EPS forecast, stock dips - Investing.com
IQVIA Beats Q1 Earnings Expectations Despite Sector Uncertainty, Company Navigating Market Conditions 'Effectively' Says CEO - Benzinga
Datadog, Marriott, IQVIA - TradingView
IQVIA Ups Revenue Forecast After Exceeding Profit Estimates - Finimize
IQV Boosts FY25 Revenue Forecast, Maintains Profit Projections | - GuruFocus
IQVIA (IQV) Exceeds Revenue Expectations with Strong Q1 Results - GuruFocus
IQVIA (NYSE:IQV) Beats Q1 Sales Targets, Full-Year Sales Guidance is Optimistic - Yahoo Finance
IQVIA Holdings Inc Reports Q1 2025 Earnings: Adjusted EPS of $2. - GuruFocus
IQVIA Holdings (IQV) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance
IQVIA Reports First-Quarter 2025 Results - BioSpace
IQVIA beats quarterly profit estimates on higher demand for research services - TradingView
IQV Boosts FY25 Revenue Forecast, Maintains Profit Projections | IQV Stock News - GuruFocus
IQVIA Holdings' Q1 Adjusted Earnings, Revenue Rise; Raises 2025 Revenue Guidance - marketscreener.com
Earnings Flash (IQV) IQVIA Holdings Posts Q1 Revenue $3.83B, vs. FactSet Est of $3.77B - marketscreener.com
IQVIA (IQV) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
(IQV) Investment Analysis - news.stocktradersdaily.com
HSBC Downgrades IQVIA Holdings (BIT:1IQV) - Nasdaq
IQVIA (IQV) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - MSN
IQVIA Gears Up to Report Q1 Earnings: What's in Store for the Stock? - Yahoo Finance
IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
IQVIA Holdings Inc. (IQV): Among Billionaire Israel Englander’s Stock Picks with Huge Upside Potential - Insider Monkey
Billionaire Israel Englander’s 10 Stock Picks with Huge Upside Potential - Insider Monkey
IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards - Business Wire
Here's What to Expect from IQVIA Holdings' Next Earnings Report - MSN
Press Release Distribution & PR Platform - ACCESS Newswire
Finanzdaten der Iqvia Holdings Inc-Aktie (IQV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):